MGX
#4293
Metagenomi Therapeutics, Inc. - Common Stock
1.3 2 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
+14.78%
6 month change
-8.33%
Year Change
-8.33%
Previous Close
1.3 2
Open
1.3 2
Low
1.3 1
High
1.3 3
Volume
52
Financials
- Market Capitalization 49.69 M
- Employee 118
- Founded 2016
- CEO N/A
- Website metagenomi.co
- Headquarter California, United States
- FIGI BBG00Y5ZXS77
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.59
Price to sales ratio
2.24
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4288 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.55 USD | +12.24% | -11.29% | +25.00% | -43.30% | 53.93 M USD | ||
| 4291 |  MCRB Seres Therapeutics, Inc. - Common Stock | 5.46 USD | +2.25% | -25.31% | -3.19% | -33.66% | 52.34 M USD | ||
| 4331 |  HYPD Hyperion DeFi, Inc. - Common Stock | 2.99 USD | +1.01% | +3.82% | +0.67% | -77.00% | 45.32 M USD | ||
| 4349 |  DYAI Dyadic International, Inc. - Common Stock | 1.20 USD | -0.83% | +17.65% | +50.00% | +21.21% | 43.73 M USD |
Frequently asked questions about Metagenomi Therapeutics, Inc. - Common Stock
What is the Metagenomi Therapeutics, Inc. - Common Stock stock price today?
The current price of Metagenomi Therapeutics, Inc. - Common Stock (MGX) is 1.32. Over the past 24 hours, the stock has changed by 0.00%. Follow the MGX chart for real-time price dynamics.
What is the stock ticker of Metagenomi Therapeutics, Inc. - Common Stock?
Metagenomi Therapeutics, Inc. - Common Stock trades under the ticker MGX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Metagenomi Therapeutics, Inc. - Common Stock stock going up?
MGX has changed by +2.33% over the last week, +14.78% over the last month, and -8.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Metagenomi Therapeutics, Inc. - Common Stock net income for the last quarter?
Metagenomi Therapeutics, Inc. - Common Stock reported net income of -23.06 M for the last quarter. The previous quarter showed -22.53 M, which means net income changed by -2.36%.
How many employees does Metagenomi Therapeutics, Inc. - Common Stock have?
As of the latest available data, Metagenomi Therapeutics, Inc. - Common Stock has 118 employees. Workforce size can provide additional context about the company's scale and operations.
What is Metagenomi Therapeutics, Inc. - Common Stock EBITDA?
Metagenomi Therapeutics, Inc. - Common Stock EBITDA is -23.67 M, and its EBITDA margin is -1 896.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Metagenomi Therapeutics, Inc. - Common Stock stock?
You can buy Metagenomi Therapeutics, Inc. - Common Stock (MGX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Metagenomi Therapeutics, Inc. - Common Stock stock?
Investing in Metagenomi Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MGX chart and related analysis on metatrader.com as part of your research.